Search results

Selected filters:

News
Litigation

Article type

Topic

Sector

Regions

Year

418 results found for your search

Sort options
21 October 2019

If you think your insurance covers you for IP disputes, you may need to think again

Recent case law in the US shows that many companies who believed their insurers should pay-out on IP-related litigation claims have been left disappointed

19 October 2019

Why the Red Hat tail will end up wagging the Big Blue dog

IBM's decision to purchase the open source powerhouse was a $34 billion bet on the future and from an IP perspective something has to give

17 October 2019

All eyes on London with globally-important FRAND appeals set for next week

The UK Supreme Court next week will be the first top court in any jurisdiction to consider the enforcement of SEPs subject to a global FRAND licensing undertaking. SEP holders and licensees will be watching closely

10 October 2019

Patent term adjustments in the US are readjusted, again

Two recent Federal Circuit decisions have shed further light on a highly litigated area of biopharma patent law

08 October 2019

An eyebrow-raising CJEU ruling could be bad news for generics

Europe’s highest court has handed down a surprising decision concerning the consequences of an “unjustified” preliminary injunction issued in a pharma patent case

01 October 2019

The top biopharma patent stories in September

Our round-up of all the major IP developments affecting the life sciences industries last month

28 September 2019

The US is gifting 5G patent leadership to others

Policy confusion and problematic court decisions mean that the shape of the IP landscape in this pivotal technology is being determined elsewhere

25 September 2019

Copyright clarification from Europe’s top court

Judges at the Court of Justice of the European Union delivered good news for designers in their Cofomel decision earlier this month

17 September 2019

Australia’s harsh approach to software patents set to continue

Observers had hoped Friday’s decision in the Encompass case would clarify key patentability questions. But a Full Bench of the Federal Court of Australia did not take the opportunity to do so

13 September 2019

Patent litigation is one reason why the UK will remain in the legal premier league

Despite the pervading sense of gloom, the quality of English courts and lawyers - and the remedies now available to plaintiffs - mean that there is an IP bright spot amidst the carnage of Brexit

11 September 2019

Software IP issues for universities have never been more complex, says tech commercialisation leader

In an exclusive interview with IAM, given in the run-up to Software IP 2019, the University of Chicago's George Chellapa describes the challenges of the fast-moving sector and how working with industry is crucial

11 September 2019

Five things to watch for from Japan’s new IP policy leadership

The new commissioner of the JPO and top cabinet advisor on IP will both address IPBC Asia in Tokyo in some of their first appearances in front of a global audience

07 September 2019

Life sciences IP - the major developments in August

All the big pharma and biotech patent stories from last month in our regular monthly round-up

28 August 2019

Asia's top IP owners revealed

Big filers, tough litigators and savvy dealmakers identified across eight industries in the run-up to IPBC Asia in Tokyo this October

24 August 2019

Adversaries no more - licensors look to make deals, not settlements

In its day, the IPNav model was hugely successful in generating cash, but successful licensing in the here and now requires a different, less confrontational approach